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Pheochromocytoma is a catecholamine-secreting tumor of the adrenal glands, usually with benign manifestations, whose typical
clinical presentation includes the triad of headache, palpitations and diaphoresis. However, a wide range of signs and symptoms
may be present. In the cardiovascular system, the most common signs are labile hypertension and sinus tachycardia. Systolic heart
failure and ST-segment deviations mimicking myocardial infarction have also been reported, as well as QT interval prolongation
and, rarely, ventricular tachycardia. We describe a challenging diagnosis of pheochromocytoma with many cardiovascular
manifestations, which could have been missed due to the absence of typical symptoms.
1.Introduction
Pheochromocytoma is a catecholamine-secreting tumor,
usually benign and localized in the adrenal gland. The classic
clinical presentation is the triad of headache, palpitations,
and diaphoresis. However, many cardiac symptoms are
present, and the most common signs are labile hypertension
and sinus tachycardia, secondary to high levels of circu-
lating catecholamine [1]. Less frequently, the tumor can
lead to myocardial dysfunction and cardiac failure, which
is reversible after surgical treatment [2–4]. Some reports
also describe ST-segment elevation mimicking myocardial
infarction (MI) and QT interval prolongation, but only a few
cases of ventricular tachycardia (VT) have been described so
far [5–10]. We report a very rare case of pheochromocytoma
presenting with a wide spectrum of cardiac manifestations.
2.CaseReport
A 62-year-old female patient was admitted to our hospital
to perform radical hysterectomy, which was complicated
by postoperative incision infection. She had a history of
systemic arterial hypertension, diabetes, and obesity. At the
20th day of admission, she complained of acute typical chest
pain, followed by ST-segment elevation in anterolateral leads
and increased CK and CK-MB serum levels, with a rise and
fall typical curve [maximum of 856mg/dL (reference range
<240mg/dL) and 154mg/dL (reference range <24mg/dL),
resp.], and diagnosis of MI was made. She was treated with
chemical thrombolysis, heparin, metoprolol, antiplatelet,
and ACE inhibitor; primary angioplasty was not attempted.
Twelve days after MI, she presented with palpitations and
was again admitted to the ICU. She had no other symptoms,
her heart rate (HR) was 160bpm, blood pressure (BP)
of 180/110mmHg, and lung ﬁelds were clear. The ECG
revealed a monomorphic VT with left bundle branch block
morphology and left axis deviation (Figure 1). Ventricular
tachycardia (VT) was reversed by intravenous amiodarone,
and maintenance dose was initiated. In order to rule out
an ischemic-related arrhythmia, a coronary angiogram was
performed, showing only a 30% obstruction at the ﬁrst
marginal branch of the left circumﬂex coronary artery, and a
discrete increase in the left ventricular diastolic volume. The
chest X-ray was normal and the echocardiogram revealed
hypokinesis of the lateral wall of the left ventricle, with a
slightly decreased ejection fraction (LVEF = 56%).
Despite amiodarone, the tachycardia episodes persisted,
and procainamide was added. Further, VT episodes became
refractory (4 to 5 recurrent VT per day), always well






















Figure 1: Ventricular tachycardia with left bundle branch block morphology and left axis deviation.
episodes of VT. An electrophysiologic study was then per-
formed aiming VT ablation, but even after many attempts
including endovenous isoproterenol, the arrhythmia could
not be induced.
Sotalol was also ineﬀective and a trial of high doses
of propranolol was used, rendering VTs less responsive to
electrical cardioversion and high blood pressure during VT.
Paradoxically, BP reduced after VT termination.
A Holter monitoring revealed bi-directional VT and
an ECG showed a QTc prolongation (560ms) (Figures
2 and 3). The characteristics of hypertension during VT
and the eﬀects of propranolol made a clinical suspicion
of pheochromocytoma, which was conﬁrmed by urinary
levels of epinephrine (683mg/24h, reference range =<20),
norepinephine (1638mg/24h, reference range = 15–80),
dopamine (660mg/24h, reference range = 65–400), and
vanilmandelic acid (13.9mg/24h, reference range =<10mg).
Magnetic resonance imaging revealed a large (46 × 48mm)
left suprarenal mass (Figure 4). No extra-adrenal pheocro-
mocytomas was observed in the paraganglion tissue of the
sympatheticnervoussystemormediastinum.Diﬀerentiation
with adenoma was made by in-phase and opposed phase
MRI. After starting treatment with phenoxybenzamine, the
BP was controlled, the QT interval normalized, and she had
norecurrencesofVTevenafterwithdrawingtheantiarrhyth-
mic drugs. Unfortunately, she developed another in-hospital
Figure 2: Holter monitoring revealing a bidirectional ventricular
tachycardia.
infection before proceeding with tumor resection. She died
2 months later as a result of multiple organ failure. Her
family refused an autopsy, and histological conﬁrmation of
pheocromocytoma was not possible.
3. Discussion
Thispapershowsanuncommonpresentationofapheochro-
mocytoma. Most of the times, this catecholamine-secreting



















Figure 3: ECG in sinus rhythm demonstrating QT interval prolongation.
the classic triad of headache, palpitations, and diaphoresis
[1]. Although these classic symptoms have a high sensitivity
(90.9%) and speciﬁcity (93.8%), the tumor can present in a
variety of clinical pattern, which can puzzle the diagnostic
investigation [1].
In this case, the ﬁrst cardiac manifestation was MI.
Some authors have already described myocardial injury
mimicking MI, with or without ST-segment elevation or
increased myocardial isoenzymes [3, 5–8, 11]. Our patient
had a typical presentation of MI and the echocardiogram
revealed segmental hypokinesis, but the coronary angiogram
showed no signiﬁcant obstructive lesions. It is believed
that the myocardial damage is caused by ischemia sec-
ondary to increased oxygen demand and vasospasm, and
a direct toxic eﬀect of plasmatic catecholamines, but not
to ischemia secondary to obstructive atherosclerosis [7].
Cardiac involvement could lead to myocardial stunning, also
called acute catecholamine myocarditis, which can be viewed
by a cardiac ultrasound as the “octopus sign” [8]. It can
eventually evolve to cardiogenic shock requiring vasoactive
drugs and left ventricular assist device implantation [4, 12].
Cardiacdysfunctionisusuallyrestoredaftertumorresection.
This patient had only mildly compromised cardiac function
though, and the “octopus sign” was not present.
Subsequently, she presented with sustained monomor-
phic VT, which has already been described [2, 11, 13].
Palpitations seen in patients with pheochromocytoma are
usually secondary to sinus tachycardia, but paroxysmal
supraventricular and ventricular arrhythmias can also occur
[2, 9, 13]. The Holter monitoring revealed bi-directional
ventricular tachycardia, which is a less sensitive but a more
speciﬁc ﬁnding, with only two reports of this association
published [2, 14].
QT prolongation has been described in 16 to 35% of
patients [11, 15], usually without a clear relationship with
clinical events, as we observed in this case. Paulin et al.
[9] have recently published a report of a patient with
pheochromocytoma, monomorphic VT, and a QTc interval
of 620ms, which also decreased after treatment. In our case,
although the tumor could not be surgically removed, the
arrhythmia ceased and the QT interval normalized after
treatment with phenoxybenzamine.
The refractoriness of VT to standard antiarrhythmic
drugs and the paradoxical increase in BP during the
episodes were important clinical clues to the diagnosis.
Hypertension is the most common cardiac manifestation in
pheochromocytoma and is labile in up to 48% of patients.
The labile nature of hypertension, a feature present in
up to 48% of patients with pheochromocytoma [1], the
recent MI without signiﬁcant coronary arteries disease, bi-
directional VT and QT prolongation also pointed to the




arrows). Right suprarenal is not seen in this view, but it was normal.
propranolol,whichworsenedthearrhythmicandBPcontrol,
led to the investigation of a cathecolamine-secreting tumor.
Sibal et al. [16] described a case series in which patients
with unsuspected pheochromocytoma had hemodynamic
deterioration after beta blockage, giving rise to cardiac
arrhythmia and labile BP.
Although suprarenal mass may be incidental during MRI
studies and histological conﬁrmation of pheocromocytoma
was not possible in our case, there are 3 important factors
for the correct diagnosis of pheocromocytoma: the clinical
presentation (especially hypertension during VT episodes),
diﬀerentiation with adenoma by in-phased and opposed-
phase MRI, and a good response to treatment with phenoxy-
benzamine, with normalization of QT interval, control of BP
and VT.
This is a good example of how challenging the diagnosis
of pheochromocytoma can be, especially when it lacks the
typical clinical picture, and is manifested by confounding
cardiovascular system events.
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